Welcome to the Oncology Congress eLearning Center, where you can access new CME /CNE/CE activities that address the latest practice gaps, emerging clinical data and new treatments options for today's cancer patients.
The activity below features content from renowned clinical experts who are committed to enhancing the quality of education and patient care. This activity was presented at the 2011 Oncology Congress Conference, held October 13-15, 2011 in San Francisco, CA.
Management of Invasive Bladder Cancer
Faculty: Randall E. Millikan, MD, The University of Texas MD Anderson Cancer Center
Length: .75 hours
Accreditation: 1 AMA PRA Category 1 Credit™ or 1.0 contact hour
Activity Overview
Activity captured from the Oncology Congress 2011 Conference focused in the program’s therapeutic area, Urologic Malignancies.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. Contemporary Forums is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians
Contemporary Forums designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Nurse Practitioners
Contemporary Forums is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity awards 1 hour.
Target Audience
The target audience for this program is oncologists, hematologist/oncologists, registered nurses, nurse practitioners, and physician assistants.
Learning Objectives
After completion of this educational activity, participants should be able to:
- Identify clinical features associated with systemic dissemination of clinically localized bladder cancer.
- Describe expected cure rate for locally advanced bladder cancers in the context of current therapy.
- Discuss the natural history of metastatic bladder cancer.
Activity Details
Release Date: December 15, 2011
Expiration Date: October 15, 2012
Full Activity Length: 1 hour
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated above. Physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period also noted above.
Follow these steps to earn CME/CNE/CE credit*:
- Read the target audience, learning objectives, and planner/author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each post-test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.
Once you complete the activity, evaluation and receive the post-test passing score, your certificate will be e-mailed to you within ten (10) business days.
Certificates/Files will be archived for 7 years.
For any content, technical issues and administrative assistance, please contact Julie Elmquist at jelmquist@cforums.com or 925-361-4821.
Disclosure Statement
All activity faculty and planners participating in continuing medical education activities sponsored by Contemporary Forums are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in their presentation and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentations.
The planning committee for this activity included Pam Jenkins-Wallace, Skip Haile and Sherlyn Celone and all have indicated that they have nothing to disclose.
Randall E. Millikan, MD has indicated that he has nothing to disclose.
Commercial Support Acknowledgement
We gratefully acknowledge the generous support of this educational activity from the following:
Abbott Laboratories, Amgen, Astellas, Celgene Corporation, Centocor Ortho Biotech, Endo Pharmaceuticals, Eisai, Genentech BioOncology, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Sanofi Aventis, Teva Pharmaceuticals, Varian Medical Systems